Your browser doesn't support javascript.
loading
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.
Thomas, Suzanne; Kuncheria, Linta; Roulstone, Victoria; Kyula, Joan N; Mansfield, David; Bommareddy, Praveen K; Smith, Henry; Kaufman, Howard L; Harrington, Kevin J; Coffin, Robert S.
Afiliação
  • Thomas S; Replimune Inc, 18 Commerce Way, Woburn, MA, 01801, USA.
  • Kuncheria L; Replimune Inc, 18 Commerce Way, Woburn, MA, 01801, USA.
  • Roulstone V; Institute for Cancer Research, London, UK.
  • Kyula JN; Institute for Cancer Research, London, UK.
  • Mansfield D; Institute for Cancer Research, London, UK.
  • Bommareddy PK; Replimune Inc, 18 Commerce Way, Woburn, MA, 01801, USA.
  • Smith H; Institute for Cancer Research, London, UK.
  • Kaufman HL; Replimune Inc, 18 Commerce Way, Woburn, MA, 01801, USA.
  • Harrington KJ; Institute for Cancer Research, London, UK.
  • Coffin RS; Replimune Inc, 18 Commerce Way, Woburn, MA, 01801, USA. Rob@replimune.com.
J Immunother Cancer ; 7(1): 214, 2019 08 10.
Article em En | MEDLINE | ID: mdl-31399043
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Herpesvirus Humano 1 / Terapia Viral Oncolítica / Herpes Simples / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Herpesvirus Humano 1 / Terapia Viral Oncolítica / Herpes Simples / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article